267 related articles for article (PubMed ID: 37204726)
41. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
[TBL] [Abstract][Full Text] [Related]
42. Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis.
Jevtic SD; Arnold DM; Modi D; Ivetic N; Bissola AL; Nazy I
Front Cardiovasc Med; 2022; 9():1040196. PubMed ID: 36352844
[TBL] [Abstract][Full Text] [Related]
43. Understanding vaccine-induced thrombotic thrombocytopenia (VITT).
Dix C; McFadyen J; Huang A; Chunilal S; Chen V; Tran H
Intern Med J; 2022 May; 52(5):717-723. PubMed ID: 35446471
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Selvadurai MV; Favaloro EJ; Chen VM
Semin Thromb Hemost; 2023 Jul; 49(5):444-452. PubMed ID: 36706782
[TBL] [Abstract][Full Text] [Related]
45. A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
Lee CSM; Liang HPH; Connor DE; Dey A; Tohidi-Esfahani I; Campbell H; Whittaker S; Capraro D; Favaloro EJ; Donikian D; Kondo M; Hicks SM; Choi PY; Gardiner EE; Clarke LJ; Tran H; Passam FH; Brighton TA; Chen VM
Blood Adv; 2022 Jun; 6(11):3494-3506. PubMed ID: 35359002
[TBL] [Abstract][Full Text] [Related]
46. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
[TBL] [Abstract][Full Text] [Related]
47. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis.
Dorgalaleh A; Shabannezhad A; Hassani S
Ann Hematol; 2023 Nov; ():. PubMed ID: 38030893
[TBL] [Abstract][Full Text] [Related]
48. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
[TBL] [Abstract][Full Text] [Related]
49. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
[TBL] [Abstract][Full Text] [Related]
50. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison.
Sachs UJ; Cooper N; Czwalinna A; Müller J; Pötzsch B; Tiede A; Althaus K
Thromb Haemost; 2021 Dec; 121(12):1622-1627. PubMed ID: 34169493
[TBL] [Abstract][Full Text] [Related]
51. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
[TBL] [Abstract][Full Text] [Related]
52. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
Greinacher A; Selleng K; Palankar R; Wesche J; Handtke S; Wolff M; Aurich K; Lalk M; Methling K; Völker U; Hentschker C; Michalik S; Steil L; Reder A; Schönborn L; Beer M; Franzke K; Büttner A; Fehse B; Stavrou EX; Rangaswamy C; Mailer RK; Englert H; Frye M; Thiele T; Kochanek S; Krutzke L; Siegerist F; Endlich N; Warkentin TE; Renné T
Blood; 2021 Dec; 138(22):2256-2268. PubMed ID: 34587242
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
54. COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets.
Pitkänen HH; Jouppila A; Helin T; Dulipati V; Kotimaa J; Meri S; Kantele A; Jalkanen P; Julkunen I; Lassila R
Thromb Res; 2021 Dec; 208():129-137. PubMed ID: 34768097
[TBL] [Abstract][Full Text] [Related]
55. Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.
Singh B; Kanack A; Bayas A; George G; Abou-Ismail MY; Kohlhagen M; Christ M; Naumann M; Moser K; Smock K; Grazioli A; Murray D; Padmanabhan A
medRxiv; 2021 Sep; ():. PubMed ID: 34611669
[TBL] [Abstract][Full Text] [Related]
56. Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions.
Marchandot B; Curtiaud A; Trimaille A; Sattler L; Grunebaum L; Morel O
Eur Heart J Open; 2021 Sep; 1(2):oeab014. PubMed ID: 35915769
[TBL] [Abstract][Full Text] [Related]
57. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
58. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
[TBL] [Abstract][Full Text] [Related]
59. Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis.
Tanhehco YC; Rux AH; Sachais BS
Transfusion; 2011 May; 51(5):1022-9. PubMed ID: 20977482
[TBL] [Abstract][Full Text] [Related]
60. Longitudinal Aspects of VITT.
Schönborn L; Greinacher A
Semin Hematol; 2022 Apr; 59(2):108-114. PubMed ID: 35512899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
